Will Morton[email protected]RSNA 2023MRI reveals brain changes in people with long COVIDMRI scans have revealed long-lasting microstructural brain changes in patients after COVID-19 infections.November 22, 2023RSNA 2023AI model identifies high-risk lung cancer in nonsmokersA group in Boston has validated an AI algorithm that could be useful for identifying nonsmokers who are at high risk of lung cancer, according to a study to be presented at RSNA 2023 in Chicago.November 22, 2023Digital X-RayHip x-rays help screen for osteoporosis in THA patientsPlain hip x-rays may help screen patients for osteoporosis before they undergo total hip arthroplasty (THA).November 21, 2023Molecular ImagingFAPI-PET shows promise for detecting pancreatic cancerFAPI-PET imaging may become a powerful diagnostic tool for detecting pancreatic cancer.November 20, 2023Molecular ImagingStudy reveals timing in Alzheimer’s disease progressionResearchers have shed light on events involved in the Alzheimer’s disease “cascade hypothesis" – namely, the timing of biomarker progression that leads to neurodegeneration.November 17, 20232023 Molecular Imaging PreviewRoad to RSNA 2023: Molecular ImagingThis is just the third year that RSNA has offered a dedicated track on nuclear medicine and molecular imaging, with eight scientific sessions covering research in prostate cancer imaging, breast cancer, cardiovascular and pulmonary imaging, and more.November 16, 2023Digital X-RayAI detects incidental lung nodules on chest x-raysAI based lesion-detection software used in daily practice can help identify clinically significant incidental lung nodules on chest x-raysNovember 16, 20232023 Molecular Imaging PreviewCan AI predict treatment response in patients with prostate cancer?An AI model based on F-18 DCFPyL PSMA-PET/CT images will be presented here that shows promise for predicting treatment response in patients with metastatic castration-resistant prostate cancer.November 15, 20232023 Molecular Imaging PreviewDoes contrast media used with PET/MRI make a difference?Findings presented during this session suggest that the use of MRI contrast agents during PET/MRI exams has no additional positive benefit for primary and follow-up staging of pediatric lymphoma patients.November 15, 20232023 Molecular Imaging PreviewCan FDG-PET/MRI radiomics help diagnose rhabdomyosarcoma in children?In this session on pediatrics and general oncology, a study will be presented that explored the value of F-18 FDG-PET/MRI radiomics features in predicting rhabdomyosarcoma in children.November 15, 2023Previous PagePage 51 of 60Next PageTop StoriesWomens ImagingKaiser score outperforms MRI BI-RADS for inconclusive breast findingsKaiser scoring led to higher diagnostic accuracy on breast MRI.Molecular ImagingFAPI-PET detects more HCC lesions than FDG-PETHomeLLMs mostly avoid unnecessary care in Choosing Wisely testsNuclear MedicineEANM: Thomas Hope on what’s next in FAP-targeted theranosticsCardiac ImagingMRI shows no ties between COVID, future heart inflammation
![Comparative PET/CT scan images showing [18F]FAPI and [18F]FDG imaging with MIP projections, fusion views, and CT cross-sections for medical diagnosis](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/10/fapi-vs-fdg.nL6Acp6W2i.jpg?auto=format%2Ccompress&fit=crop&h=167&q=70&w=250)
